Investing.com - Financial Markets Worldwide
Get 40% Off
Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Stocks - Teva, Tilray, Canopy Growth Soar in Pre-market; Tesla, Amazon Fall

Published 09/17/2018, 08:30 AM
© Reuters. Stocks in focus in pre-market trade on Monday

Investing.com - Stocks in focus in pre-market trade Monday:

• Teva (NYSE:TEVA) stock surged 8.03% by 8:00 AM ET (12:00 GMT) after the U.S. Food and Drug Administration approved the company's migraine treatment.

• Tilray (NASDAQ:TLRY) stock surged 6.86%, while Canopy Growth (NYSE:CGC) rose 2.01% as Bloomberg reported that Coca-Cola (NYSE:KO) was in talks with Canadian marijuana producer Aurora Cannabis (TO:ACB) to make cannabis-infused beverages.

• Tesla (NASDAQ:TSLA) stock slipped 0.41% as chief executive Elon Musk said over the weekend that the company’s problems have shifted from production delays to delivery logistics. Musk also indicated that Tesla will bring most collision repairs in-house.

• Amazon.com (NASDAQ:AMZN) stock lost 0.62% as the company investigates a report that its employees were accepting bribes to provide confidential internal data and other services in exchange for a fee.

• Meredith (NYSE:MDP) stock could see movement in the regular session after it agreed to sell the Time media brand for $190 million to Salesforce.com (NYSE:CRM) chairman Marc Benioff and his wife Lynne.

• Tyson Foods (NYSE:TSN) stock fell 2.21% as the company announced that Noel White would replace Tom Hayes as president and chief executive. The company also reaffirmed its guidance for earnings per share in fiscal 2018.

• DowDuPont (NYSE:DWDP) stock may see movement in the regular session as the company announced that chief executive Edward Breen will take over as the executive chairman of its specialty-products unit when it separates into three units.

• Select Income REIT (NASDAQ:SIR) skyrocketed 20.19% after it agreed to merge with Government Properties Income Trust (NASDAQ:GOV).

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

• Fiat Chrysler Automobiles (NYSE:FCAU) stock may see movement in the regular session after the company reportedly decided to look for other bidders for Magneti Marelli as it considers KKR’s sub-$7 billion offer to be too low, according to Bloomberg.

• Mersana Therapeutics (NASDAQ:MRSN) stock jumped 7.8% after the Food and Drug Administration lifted a clinical hold on its cancer therapy.

Latest comments

• Teva (NYSE:TEVA) stock surged 8.03% by 8:00 AM ET (12:00 GMT) after the U.S. Food and Drug Administration approved the company's migraine treatment.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.